Topics
Gliomas | Overall management | IDH-mutant
Home > Publications > Topics > Gliomas > Overall management > IDH-mutant
Jiang H, Wang X, Chen X, Zhang S, Ren Q, Li M, Li M, Ren X, Lin S,
Cui Y.
Unraveling the heterogeneity of
WHO grade 4 gliomas: insights from clinical, imaging, and
molecular characterization.
Discov
Oncol. 2025 Feb 3;16(1):111. doi:
10.1007/s12672-025-01811-0. PMID:
39899184. Observational study. ˍ
*Lanman T, Densmore I, Nagpal S, Recht L, McGranahan T.
Characteristics and Outcomes of
Patients With IDH-Mutant Grade 2 and 3 Gliomas After Deferred or
Adjuvant Radiotherapy. Neurology.
2025 Jun 13;105(1):e213797. doi:
10.1212/WNL.0000000000213797. PMID:
40513058. Observational study.
ˍ